Skip to main content
REGN logo

REGN · Regeneron Pharmaceuticals, Inc.

Track REGN — free
$803.48 -2.49 (-0.31%) At close · Aug 14
Market Cap
$82.16B
Shares
102.95M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-08-10 Guarini Kathryn 400
2026-08-10 Zoghbi Huda Y 800
2026-02-19 Zoghbi Huda Y 1,638
2026-02-09 Arthur F. Ryan 400
2026-02-09 Pitofsky Jason 2,036
2026-01-07 Bassler Bonnie L 1,500
2025-11-20 Bassler Bonnie L 760
2025-11-07 Jason Pitofsky 431
2024-11-01 MARION E MCCOURT 1,000
2024-10-01 MARION E MCCOURT 1,000
2024-09-03 MARION E MCCOURT 1,000
2024-08-28 Christopher Fenimore 5,680
2024-08-15 Bassler Bonnie L 756
2024-08-14 MURPHY ANDREW J 6,363
2024-08-08 Neil Stahl 5,197
2024-08-07 Jason Pitofsky 487
2024-08-02 Bassler Bonnie L 756
2024-08-01 MARION E MCCOURT 1,137
2024-08-01 Arthur F. Ryan 300
2024-07-01 MARION E MCCOURT 1,137
2024-06-24 Bassler Bonnie L 756
2024-06-14 MICHAEL S BROWN 1,535
2024-06-12 SCHLEIFER LEONARD S 1,000
2024-06-06 SCHLEIFER LEONARD S 25,000
2024-06-05 Bassler Bonnie L 827
2024-06-03 MARION E MCCOURT 1,138
2024-05-28 MICHAEL S BROWN 1,172
2024-05-21 LAROSA JOSEPH J 3,731
2024-05-15 YANCOPOULOS GEORGE 100,000
2024-05-14 SCHLEIFER LEONARD S 58,771
2024-05-01 MARION E MCCOURT 250
2024-05-01 Arthur F. Ryan 300
2024-04-01 MARION E MCCOURT 250
2024-03-14 MURPHY ANDREW J 5,783
2024-03-01 MARION E MCCOURT 358
2024-02-26 Joseph LaRosa 3,000
2024-02-26 Bassler Bonnie L 854
2024-02-26 GEORGE L. SING 1,000
2024-02-23 GEORGE L. SING 500
2024-02-22 Robert Landry 3,100
2024-02-22 GEORGE L. SING 3,000
2024-02-09 GEORGE L. SING 500
2024-02-09 Christopher Fenimore 4,919
2024-02-08 GEORGE L. SING 500
2024-02-08 Landry Robert E 6,311
2024-02-07 Neil Stahl 8,037
2024-02-07 Robert Landry 2,500
2024-02-07 Joseph LaRosa 2,000
2024-02-05 McCourt Marion 1,000
2024-02-01 Arthur Ryan 300
Showing 1–50 of 78 filings
Key facts CIK 872589 CUSIP 75886F107 13F (30d) 1219 filings 1179 filers Visit website Investor relations